GFAP and obesity disorder: According to previous studies [58,59], HFD intake and obesity induce glia activation and central neural inflammation, as demonstrated by an increase of the gliosis marker GFAP as well as pro-inflammatory mediators (NF-kB, IL-6 and IL-1β) and the infiltration of immune cells.